Brevan Howard Capital Management’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,773
Closed -$251K 2405
2025
Q4
$251K Buy
+9,773
New +$225K ﹤0.01% 1467
2025
Q3
Sell
-43,893
Closed -$966K 2200
2025
Q2
$966K Sell
43,893
-57,562
-57% -$1.26M 0.01% 1080
2025
Q1
$2.27M Buy
101,455
+49,040
+94% +$1.06M 0.02% 275
2024
Q4
$904K Buy
+52,415
New +$813K 0.01% 457
2024
Q3
Sell
-7,405
Closed -$212K 1360
2024
Q2
$212K Buy
+7,405
New +$223K ﹤0.01% 872
2024
Q1
Sell
-7,853
Closed -$292K 1276
2023
Q4
$292K Buy
+7,853
New +$264K ﹤0.01% 722

Other funds holding PGNY

Brevan Howard Capital Management's PGNY Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Progyny (PGNY) in Q1 2026, closing a stake of 9,773 shares — an estimated $251K sold.

Brevan Howard Capital Management first reported a position in PGNY in Q4 2023 and held it in 6 quarters. The position peaked at $2.27M in Q1 2025. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Progyny position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 9,773 Progyny shares in Q1 2026, an estimated $251K.
  • Brevan Howard Capital Management first reported a position in Progyny in Q4 2023 and held it in 6 quarters.
  • Brevan Howard Capital Management's Progyny position peaked at $2.27M in Q1 2025.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.